ReviewClinical cancer research : an official journal of the American Association for Cancer Research2021

Opportunities for Utilization of DNA Repair Inhibitors in Homologous Recombination Repair-Deficient and Proficient Pancreatic Adenocarcinoma.

James M Cleary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.